Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
Details for Australian Patent Application No. 2002308348 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 84/2001 06.04.01 CU
10 April 2003 Application Open to Public Inspection
Published as AU-B-2002308348
2 February 2006 Amendment Made
The nature of the amendment is: Amend the name of the applicant from Centro De Immunologia Molecular to Centro De Inmunologia Molecular
22 November 2007 Application Accepted
Published as AU-B-2002308348
20 March 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002308347-Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser